Suppr超能文献

恶性疟原虫天冬氨酸蛋白酶-i中的二硫键是其加工活性和多毫克重组生产产量的关键要素。

Disulfide linkages in Plasmodium falciparum plasmepsin-i are essential elements for its processing activity and multi-milligram recombinant production yield.

作者信息

Lolupiman Sirisak, Siripurkpong Pilaiwan, Yuvaniyama Jirundon

机构信息

Department of Biochemistry and Center for Excellence in Protein Structure and Function, Faculty of Science, Mahidol University, Bangkok, Thailand.

Department of Medical Technology, Faculty of Allied Health Sciences, Thammasat University, Pathumthani, Thailand.

出版信息

PLoS One. 2014 Feb 20;9(2):e89424. doi: 10.1371/journal.pone.0089424. eCollection 2014.

Abstract

Plasmodium falciparum plasmepsin-I (PM-I) has been considered a potential drug target for the parasite that causes fatal malaria in human. Determination of PM-I structures for rational design of its inhibitors is hindered by the difficulty in obtaining large quantity of soluble enzyme. Nearly all attempts for its heterologous expression in Escherichia coli result in the production of insoluble proteins in both semi-pro-PM-I and its truncated form, and thus require protein refolding. Moreover, the yields of purified, soluble PM-I from all reported studies are very limited. Exclusion of truncated semi-pro-PM-I expression in E. coli C41(DE3) is herein reported. We also show that the low preparation yield of purified semi-pro-PM-I with autoprocessing ability is mainly a result of structural instability of the refolded enzyme in acidic conditions due to incomplete formation of disulfide linkages. Upon formation of at least one of the two natural disulfide bonds, nearly all of the refolded semi-pro-PM-I could be activated to its mature form. A significantly improved yield of 10 mg of semi-pro-PM-I per liter of culture, which resulted in 6-8 mg of the mature PM-I, was routinely obtained using this strategy.

摘要

恶性疟原虫天冬氨酸蛋白酶-I(PM-I)被认为是导致人类致命疟疾的疟原虫的一个潜在药物靶点。由于难以获得大量可溶性酶,阻碍了为合理设计其抑制剂而对PM-I结构的测定。几乎所有在大肠杆菌中进行其异源表达的尝试都导致在半前体PM-I及其截短形式中产生不溶性蛋白质,因此需要蛋白质复性。此外,所有已报道研究中纯化的可溶性PM-I的产量都非常有限。本文报道了在大肠杆菌C41(DE3)中排除截短的半前体PM-I的表达。我们还表明,具有自加工能力的纯化半前体PM-I制备产量低,主要是由于在酸性条件下复性酶的结构不稳定,这是由于二硫键形成不完全所致。在形成两个天然二硫键中的至少一个后,几乎所有复性的半前体PM-I都可以被激活为其成熟形式。使用该策略常规获得了显著提高的产量,每升培养物可产生10 mg半前体PM-I,从而得到6 - 8 mg成熟的PM-I。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cee1/3930733/323593461a1b/pone.0089424.g001.jpg

相似文献

2
The zymogen of plasmepsin V from Plasmodium falciparum is enzymatically active.
Mol Biochem Parasitol. 2014 Oct;197(1-2):56-63. doi: 10.1016/j.molbiopara.2014.10.004. Epub 2014 Oct 25.
4
Expression and characterisation of plasmepsin I from Plasmodium falciparum.
Eur J Biochem. 1997 Mar 1;244(2):552-60. doi: 10.1111/j.1432-1033.1997.00552.x.
5
The nepenthesin insert in the Plasmodium falciparum aspartic protease plasmepsin V is necessary for enzyme function.
J Biol Chem. 2022 Sep;298(9):102355. doi: 10.1016/j.jbc.2022.102355. Epub 2022 Aug 9.
6
Yield improvement and enzymatic dissection of Plasmodium falciparum plasmepsin V.
Mol Biochem Parasitol. 2019 Jul;231:111188. doi: 10.1016/j.molbiopara.2019.111188. Epub 2019 May 17.
7
Enzymatic Characterization of Recombinant Food Vacuole Plasmepsin 4 from the Rodent Malaria Parasite Plasmodium berghei.
PLoS One. 2015 Oct 28;10(10):e0141758. doi: 10.1371/journal.pone.0141758. eCollection 2015.
8
Recombinant expression and enzymatic subsite characterization of plasmepsin 4 from the four Plasmodium species infecting man.
Mol Biochem Parasitol. 2004 May;135(1):101-9. doi: 10.1016/j.molbiopara.2004.01.010.
9
Expression and enzymatic characterization of the soluble recombinant plasmepsin I from Plasmodium falciparum.
Protein Eng Des Sel. 2007 Dec;20(12):625-33. doi: 10.1093/protein/gzm066. Epub 2007 Dec 10.

引用本文的文献

2
A Putative Non-Canonical Ras-Like GTPase from P. falciparum: Chemical Properties and Characterization of the Protein.
PLoS One. 2015 Nov 5;10(11):e0140994. doi: 10.1371/journal.pone.0140994. eCollection 2015.

本文引用的文献

1
Crystal structures of the free and inhibited forms of plasmepsin I (PMI) from Plasmodium falciparum.
J Struct Biol. 2011 Jul;175(1):73-84. doi: 10.1016/j.jsb.2011.04.009. Epub 2011 Apr 20.
2
Crystal structures of the histo-aspartic protease (HAP) from Plasmodium falciparum.
J Mol Biol. 2009 May 8;388(3):520-40. doi: 10.1016/j.jmb.2009.03.011. Epub 2009 Mar 11.
4
Expression and enzymatic characterization of the soluble recombinant plasmepsin I from Plasmodium falciparum.
Protein Eng Des Sel. 2007 Dec;20(12):625-33. doi: 10.1093/protein/gzm066. Epub 2007 Dec 10.
5
Plasmepsins as potential targets for new antimalarial therapy.
Med Res Rev. 2006 Sep;26(5):626-66. doi: 10.1002/med.20082.
6
Plasmodium falciparum ensures its amino acid supply with multiple acquisition pathways and redundant proteolytic enzyme systems.
Proc Natl Acad Sci U S A. 2006 Jun 6;103(23):8840-5. doi: 10.1073/pnas.0601876103. Epub 2006 May 26.
7
Recombinant expression and partial characterization of an active soluble histo-aspartic protease from Plasmodium falciparum.
Protein Expr Purif. 2006 Sep;49(1):88-94. doi: 10.1016/j.pep.2006.02.022. Epub 2006 Apr 3.
8
Hemoglobin degradation.
Curr Top Microbiol Immunol. 2005;295:275-91. doi: 10.1007/3-540-29088-5_11.
9
Malaria.
Lancet. 2005;365(9469):1487-98. doi: 10.1016/S0140-6736(05)66420-3.
10
The global distribution of clinical episodes of Plasmodium falciparum malaria.
Nature. 2005 Mar 10;434(7030):214-7. doi: 10.1038/nature03342.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验